IVVD

Invivyd (IVVD)

Invivyd Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IVVD

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	20:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IVVD	Invivyd Inc
2024/05/31	20:05	GlobeNewswire Inc.	Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial	NASDAQ:IVVD	Invivyd Inc
2024/05/31	20:00	GlobeNewswire Inc.	Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer	NASDAQ:IVVD	Invivyd Inc
2024/05/29	20:00	GlobeNewswire Inc.	Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)	NASDAQ:IVVD	Invivyd Inc
2024/05/24	07:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/24	07:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/24	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/24	05:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/24	05:50	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/22	20:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IVVD	Invivyd Inc
2024/05/22	20:00	GlobeNewswire Inc.	Invivyd Elects Two New Independent Members to its Board of Directors	NASDAQ:IVVD	Invivyd Inc
2024/05/17	05:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IVVD	Invivyd Inc
2024/05/14	05:01	GlobeNewswire Inc.	Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference	NASDAQ:IVVD	Invivyd Inc
2024/05/10	05:32	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IVVD	Invivyd Inc
2024/05/10	05:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IVVD	Invivyd Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IVVD	Invivyd Inc
2024/05/10	05:01	GlobeNewswire Inc.	Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:IVVD	Invivyd Inc
2024/05/07	20:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IVVD	Invivyd Inc
2024/05/07	20:30	GlobeNewswire Inc.	Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback	NASDAQ:IVVD	Invivyd Inc
2024/05/03	06:13	GlobeNewswire Inc.	Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights	NASDAQ:IVVD	Invivyd Inc
2024/04/30	20:30	GlobeNewswire Inc.	Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position	NASDAQ:IVVD	Invivyd Inc
2024/04/15	20:30	GlobeNewswire Inc.	Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™	NASDAQ:IVVD	Invivyd Inc
2024/04/12	20:30	GlobeNewswire Inc.	Invivyd Announces CEO Transition	NASDAQ:IVVD	Invivyd Inc
2024/04/05	05:01	GlobeNewswire Inc.	Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million	NASDAQ:IVVD	Invivyd Inc
2024/03/28	20:00	GlobeNewswire Inc.	Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:IVVD	Invivyd Inc
2024/03/23	04:28	GlobeNewswire Inc.	Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial	NASDAQ:IVVD	Invivyd Inc
2024/03/23	04:04	GlobeNewswire Inc.	Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19	NASDAQ:IVVD	Invivyd Inc
2024/02/13	06:01	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IVVD	Invivyd Inc
2024/02/10	06:47	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IVVD	Invivyd Inc
2024/02/10	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IVVD	Invivyd Inc